A non-cardiovirulent strain of coxsackievirus B3 causes myocarditis in mice with severe combined immunodeficiency syndrome
- PMID: 8682092
- DOI: 10.1093/eurheartj/16.suppl_o.18
A non-cardiovirulent strain of coxsackievirus B3 causes myocarditis in mice with severe combined immunodeficiency syndrome
Abstract
The most extensively studied animal model of coxsackievirus B3 (CVB3)-induced inflammatory heart muscle disease is the murine model. In the acute and chronic phase of the disease, it has been suggested that autoimmune mechanisms play a major role in the pathogenesis of the disease. In this study, C3H mice without functional T- and B-lymphocytes (C3H SCID) were inoculated either with a cardiovirulent (CVB3/20) or a non-cardiovirulent (CVB3/0) strain of coxsackievirus B3. Both viruses caused myocarditis in SCID mice. Furthermore, it could be demonstrated, that CVB3/0 had mutated to a cardiovirulent phenotype, able to cause myocarditis in immunocompetent mice.
Similar articles
-
Genetics of coxsackievirus B3 cardiovirulence.Eur Heart J. 1995 Dec;16 Suppl O:15-7. doi: 10.1093/eurheartj/16.suppl_o.15. Eur Heart J. 1995. PMID: 8682085
-
Coxsackievirus B3 induces apoptosis in the early phase of murine myocarditis: a comparative analysis of cardiovirulent and noncardiovirulent strains.Intervirology. 2003;46(3):135-40. doi: 10.1159/000071453. Intervirology. 2003. PMID: 12867750
-
Coxsackievirus-induced chronic myocarditis in murine models.Eur Heart J. 1995 Dec;16 Suppl O:56-8. doi: 10.1093/eurheartj/16.suppl_o.56. Eur Heart J. 1995. PMID: 8682103
-
Manipulating intestinal immunity and microflora: an alternative solution to viral myocarditis?Future Microbiol. 2012 Oct;7(10):1207-16. doi: 10.2217/fmb.12.96. Future Microbiol. 2012. PMID: 23030425 Review.
-
Studies of virus-induced myocardial injury in mice: value of the scid mutation on different genetic backgrounds and combined with other mutations.Lab Anim Sci. 1993 Apr;43(2):133-5. Lab Anim Sci. 1993. PMID: 8391609 Review.
Cited by
-
Research progress and application prospects of animal models of group B Coxsackievirus infections.Emerg Microbes Infect. 2025 Dec;14(1):2441391. doi: 10.1080/22221751.2024.2441391. Epub 2024 Dec 22. Emerg Microbes Infect. 2025. PMID: 39665300 Free PMC article. Review.
-
An aged host promotes the evolution of avirulent coxsackievirus into a virulent strain.Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13825-30. doi: 10.1073/pnas.0605507103. Epub 2006 Sep 1. Proc Natl Acad Sci U S A. 2006. PMID: 16950876 Free PMC article.
-
Molecular determinants of disease in coxsackievirus B1 murine infection.J Med Virol. 2011 Sep;83(9):1571-81. doi: 10.1002/jmv.22133. J Med Virol. 2011. PMID: 21739448 Free PMC article.
-
Nucleotide differences of coxsackievirus B3 and chronic myocarditis.Heart Vessels. 2015 Jan;30(1):126-35. doi: 10.1007/s00380-014-0478-7. Epub 2014 Feb 4. Heart Vessels. 2015. PMID: 24493328
-
5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.J Virol. 2005 Jun;79(11):7024-41. doi: 10.1128/JVI.79.11.7024-7041.2005. J Virol. 2005. PMID: 15890942 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources